In
this study, blueberry (Vaccinium ssp.) anthocyanins
(VA) and blackberry (Rubus L.) anthocyanins (RA)
were used to investigate the effects on metabolic syndrome (MetS)
and the potential mechanisms. Importantly, all of the data presented
in this study were obtained from experiments conducted on mice. As
a result, VA and RA reduced body weight gain and fat accumulation
while improving liver damage, inflammation, glucose, and lipid metabolism
induced by a high-fat diet. Moreover, VA and RA regulated the gut
microbiota composition, decreasing the pro-obesity and proinflammation
bacteria taxa, such as the phylum Actinobacterium and the genera Allobaculum and Bifidobacterium, and increasing
those negatively associated with obesity and inflammation, such as
the phylum Bacteroidetes and the genera Prevotella and Oscillospira. Additionally, the supplementation
with VA and RA reversed the elevated levels of valeric, caproic, and
isovaleric acids observed in the high-fat diet (HFD) group, bringing
them closer to the levels observed in the Chow group. This reversal
indicated that alterations in the composition and abundance of gut
microbiota may contribute to the restoration of short-chain fatty
acids (SCFAs) levels. Additionally, PICRUSt2 exhibited that cyanamino
acid metabolism and betalain biosynthesis might be the major metabolic
pathways in the HVA group compared with the HFD group, while in the
HRA group, it was the phosphotransferase system. These findings suggest
that VA and RA can ameliorate MetS by modulating the gut microbiota
and production of SCFAs.